Eli Lilly and Company CEDEAR Logo

Eli Lilly and Company CEDEAR (LLYD)

BCBA

Currency in USD
23.38
+0.18 (+0.78%)

Closed

Aug 21, 2026

Day's Range

23.05
23.65

52 wk Range

12.20
23.94

Analyst Ratings - LLYD - Eli Lilly and Company CEDEAR

Analyst ratings

DateFirmActionRating
Oct 11, 2023Morgan StanleyMaintainsOverweight
Oct 09, 2023Cantor FitzgeraldReiteratesOverweight
Oct 09, 2023Wells FargoMaintainsOverweight
Oct 02, 2023Cantor FitzgeraldReiteratesOverweight
Sep 05, 2023Argus ResearchMaintainsBuy
Sep 05, 2023Cantor FitzgeraldReiteratesOverweight
Sep 05, 2023Morgan StanleyMaintainsOverweight
Aug 22, 2023Cantor FitzgeraldReiteratesOverweight
Aug 10, 2023Goldman SachsMaintainsNeutral
Aug 09, 2023BarclaysMaintainsOverweight
Items per row:

Estimates - LLYD - Eli Lilly and Company CEDEAR

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - LLYD - Eli Lilly and Company CEDEAR

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-04-28-----
2026-03-20--0.18-0.15+0.03‪-16.67%‬
2025-12-04-0.920.94+0.02‪+2.17%‬
2025-11-20-2.912.98+0.07‪+2.41%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.